Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

NK cells that populate the decidua are important regulators of normal placentation. In contrast to peripheral blood NK cells, decidual NK (dNK) cells lack cytotoxicity, secrete proangiogenic factors, and regulate trophoblast invasion. In this study we show that exposure to a combination of hypoxia, TGF-β1, and a demethylating agent results in NK cells that express killer cell Ig-like receptors, the dNK cell markers CD9 and CD49a, and a dNK pattern of chemokine receptors. These cells secrete vascular endothelial growth factor (a potent proangiogenic molecule), display reduced cytotoxicity, and promote invasion of human trophoblast cell lines. These findings have potential therapeutic applications for placental disorders associated with altered NK cell biology.

More information Original publication

DOI

10.4049/jimmunol.1202582

Type

Journal article

Publication Date

2013-04-15T00:00:00+00:00

Volume

190

Pages

3939 - 3948

Total pages

9

Keywords

Angiogenic Proteins, Azacitidine, CD56 Antigen, Cell Line, Transformed, Cell Movement, Cytoplasmic Granules, Decidua, Decitabine, Female, GPI-Linked Proteins, Human Umbilical Vein Endothelial Cells, Humans, Immunophenotyping, Killer Cells, Natural, Receptors, IgG, Receptors, KIR